Cargando…
Prediction of Recurrence-associated Death from Localized Prostate Cancer with a Charlson Comorbidity Index–reinforced Machine Learning Model
Research has failed to resolve the dilemma experienced by localized prostate cancer patients who must choose between radical prostatectomy (RP) and external beam radiotherapy (RT). Because the Charlson Comorbidity Index (CCI) is a measurable factor that affects survival events, this research seeks t...
Autores principales: | Lin, Yi-Ting, Lee, Michael Tian-Shyug, Huang, Yen-Chun, Liu, Chih-Kuang, Li, Yi-Tien, Chen, Mingchih |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698054/ https://www.ncbi.nlm.nih.gov/pubmed/31428684 http://dx.doi.org/10.1515/med-2019-0067 |
Ejemplares similares
-
Does the Charlson comorbidity index help predict the risk of death in COVID-19 patients?
por: Comoglu, Senol, et al.
Publicado: (2022) -
Age-adjusted Charlson comorbidity index in recurrent glioblastoma: a new prognostic factor?
por: Barz, Melanie, et al.
Publicado: (2022) -
Charlson Comorbidity Index Score and Risk of Severe Outcome and Death in Danish COVID-19 Patients
por: Christensen, Daniel Mølager, et al.
Publicado: (2020) -
Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden
por: Ludvigsson, Jonas F, et al.
Publicado: (2021) -
Analysis of the Impact of Comorbidities on Endometrial Lesions Using the Charlson Comorbidity Index in Western Romania
por: Furau, Alexandru, et al.
Publicado: (2021)